Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia: Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT)

Cited by (259)

Items 201–259 of 259

  1. Japanese Society of Hypertension
    Guidelines for the Management of Hypertension (JSH 2004) · 2006 · Hypertension Research
  2. Chapter 7. Hypertension complicated by other diseases
    2014 · Hypertension Research
  3. Statins Have No Role in Pulmonary Disease Mortality
    Eddie Vos, Luca Mascitelli · 2007 · CHEST Journal
  4. Risk Evaluation of Coronary Heart Disease and Cerebrovascular Disease by the Japan Atherosclerosis Society Guidelines 2002 Using the Cohort of the Holicos-PAT Study
    Junji Koizumi, Masami Shimizu, Susumu Miyamoto, Ryoyu Takeda, Takio Ohka, Honin Kanaya, Yoshihide Uno, Kousei Ueda, Tadayoshi Takegoshi, Takanobu WAKASUGI et al. · 2005 · Journal of Atherosclerosis and Thrombosis
  5. Relationship between LDL-C Reduction after Coronary Revascularization and Prevention of Recurrence of Cardiovascular Events
    Tatsuhiro Nishiwaki, Mitsutoshi Satoh, Daisuke Kishi, Fumihiko Yoshie, Keiko Fukuda, Chikao Ibuki, Yoshihiko Seino · 2010 · Journal of Pharmacy & Pharmaceutical Sciences
  6. Japan atherosclerosis society guidelines for prevention of atherosclerotic diseases in Japanese
    Tamio Teramoto · 2008 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  7. Other High-Risk Conditions
    Tamio Teramoto, Junichi Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida et al. · 2013 · Journal of Atherosclerosis and Thrombosis
  8. Are statins overused?
    Malcolm E Kendrick · 2007 · Future Lipidology
  9. Hyperlipidemia effects on clinical indexes of stroke in Japanese patients
    Yoichi Ogushi, Yasuo Haruki, Takeo Shibata, Shotai Kobayashi, JSSRS Group · 2010 · Nosotchu
  10. Statins for women, elderly: Malpractice?
    Eddie Vos · 2007 · Nutrition Metabolism and Cardiovascular Diseases
  11. Pharmacoeconomic Analysis of HMG-CoA Reductase Inhibitors
    Tsutomu Takahashi, Miwako Kamei, Yoshiyasu Saegusa, Yukie Takimoto, Makoto Shiragami · 2006 · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
  12. Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative’
    Uffe Ravnskov · 2017 · British Journal of Cancer
  13. Needs to Change the Direction of Cholesterol-related Medication—A Problem of Great Urgency
    Harumi Okuyama · 2005 · YAKUGAKU ZASSHI
  14. Relationships between inflammatory mediators and coronary plaque composition in patients with stable angina investigated by ultrasound radiofrequency data analysis
    Shinji Satoh, Etsuo Mori, Katsuhiko Takenaka, Takahiro Mori, Hiroko Inoue, Kotaro Numaguchi, Koji Hiyamuta · 2011 · Cardiovascular Intervention and Therapeutics
  15. LDL Cholesterol: ìBadî Cholesterol, or Bad Science?
    Anthony Colpo · 2005
  16. Lipid Nutrition Guidelines
    Harumi Okuyama, Sherif Sultan, Naoki Ohara, Tomohito Hamazaki, Peter H. Langsjoen, Rokuro Hama, Yoichi Ogushi, Tetsuyuki Kobayashi, Shunji Natori, Hajime Uchino et al. · 2021 · MDPI eBooks
  17. Effects of Stopping to Eat Eggs and Drink Milk in Japanese with Hypercholesterolemia
    Hirohiko Kojima · 2005 · Health Evaluation and Promotion
  18. Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patients.
    Eddie Vos · 2007 · Canadian Journal of Cardiology
  19. Misleading Recent Papers on Statin Drugs in Peer-Reviewed Medical Journals
    Joel M. Kauffman · 2007
  20. Strokes, cholesterol and statins: When mortality is an endpoint
    Eddie Vos, Pierre Biron · 2018 · Atherosclerosis
  21. DHCR24 Promotes Melanoma Stem-Like Cells Formation and Mediates Vemurafenib Resistance by Accumulating 27-Hydroxycholesterol
    Feiliang Zhong, Tingting Chen, Jia Liu, Ying Wang, Mingdong Yao, Bo Li · 2021 · Research Square
  22. Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
    Uffe Ravnskov, Kilmer S. McCully · 2022 · Frontiers in Oncology
  23. Atividade física, condicionamento cardiorrespiratório, estado nutricional, adipocitocinas e suas relações com fatores de risco cardiovascular em homens com idade superior a 35 anos
    Eduardo Camillo Martinez · 2009 · Americanae (AECID Library)
  24. Regulació de l’expressió gènica en monòcits/macròfags per factors pro-aterogènics. Modulació farmacològica
    Jordi Pou Sánchez · 2011 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  25. Impact of Gastrectomy on High-Density Lipoprotein Cholesterol Elevation in Nonobese Patients During a 10-Year Follow-up
    Shigetsugu Tsuji, Atsushi Nohara, Yoshiaki Hayashi, Isao Yoshida, Rie Oka, Tadashi Moriuchi, Tomomi Hagishita, Susumu Miyamoto, Ayako Suzuki, Toshihide Okada et al. · 2014 · Journal of Atherosclerosis and Thrombosis
  26. Helicobacter pylori Infection and High-density Lipoprotein Cholesterol in Japanese Women: the JMS Cohort Study
    Reiko Yamamoto, Shizukiyo Ishikawa, Masafumi Mizooka, Eiji Kajii · 2012 · General Medicine
  27. Estimation of Effect of Lipid Lowering Treatment on Total Mortality Rate and Its Cost-Effectiveness Determined by Intervention Study of Hypercholesterolemia
    Chihoko Kame, Akira Babazono, Eiji YAMAMOTO · 2007 · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene)
  28. The Japanese Experience
    Tomohito Hamazaki, Harumi Okuyama · 2008 · Humana Press eBooks
  29. Comparison of Serum Lipid Management According to Japan Atherosclerosis Society 2007 and 2012 Guidelines: Analysis of Data from Ningen Dock Database
    Eiko Takahashi, Kengo Moriyama, Minoru Yamakado · 2014
  30. Effect of Alogliptin, a DPP-4 Inhibitor, on Markers of Lipid Metabolism in Type 2 Diabetic Patients
    Yuzuru Kishitani · 2014 · International Journal of Diabetes and Clinical Research
  31. Statins stimulate atherosclerosis and heart failure: pharmacological
    Harumi Okuyama, Peter H. Langsjoen, Tomohito Hamazaki, Yoichi Ogushi, Rokuro Hama, Tetsuyuki Kobayashi, Hajime Uchino · 2015
  32. Statin-Induced Low Low-Density Lipoprotein Cholesterol Level
    Luca Mascitelli, Mark R. Goldstein · 2015 · Journal of the American College of Cardiology
  33. The Japanese experience: high cholesterol is not an important risk factor of all-cause mortality.
    Tomohito Hamazaki, Harumi Okuyama, Fabien De Meester, RONALD ROSS WATSON · 2008
  34. The relationship between cholesterol concentration and carotid intima media thickness differs according to gender and menopausal status in Korean type 2 diabetic patients
    Hye-Kyung Chung, Yu-Sik Kim, Ji Sun Nam, Chul Woo Ahn · 2016 · Clinica Chimica Acta
  35. Risk Factors and Serum Cholesterol Concentrations in the Patients Given HMG-CoA Reductase Inhibitor, Pravastatin
    Shinya Uchida, Hiroshi Watanabe, Masumi GOTO, Toshio Maeda, Hisakuni Hashimoto, Masahiro NAKANO, Kyoichi Ohashi · 2005 · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
  36. Relationship of low- and high-density lipoprotein cholesterol with atherosclerosis
    Cheng-cheng YI, WEN-wen Liu, Ying-qiu ZHANG, Zhijun Guo, Xiang-yun WANG, Zhi-zhong YUAN, Changlin Zhou, Ren-fu YIN · 2011 · Academic Journal of Second Military Medical University
  37. 14. Dyslipidemia and Coronary Disease
    Hiroyuki Daita, Hirotoshi Ohmura · 2009 · Nihon Naika Gakkai Zasshi
  38. Erratum: The Relationship Between Low-Density Lipoprotein Cholesterol Levels and the Incidence of Cardiovascular Disease in High-Risk Patients Treated With Pravastatin
    Hiroyuki Daida, Tamio Teramoto, Yasuhisa Kitagawa, Yasuyuki Matsushita, Masahiro Sugihara, on behalf of the APPROACH-J Study Group · 2014 · International Heart Journal
  39. 6. Guideline for Hyperlipidemia and Its Validation
    Tamio Teramoto · 2009 · Nihon Naika Gakkai Zasshi
  40. 2. Evidence of Lipid Intervention in Japanese
    Shizuya Yamashita · 2009 · Nihon Naika Gakkai Zasshi
  41. Effects of alcoholic quantity, number of cigarettes and exercise habit on HDL cholesterol in male drinkers and smokers
    Emiko Kikuchi, Kanae Oda, Tetsuzo Sen, Kiyoshi Kawakubo · 2016 · Health Evaluation and Promotion
  42. Should We Aggressively Treat the Patient with High Levels of Cholesterol Even in Japanese?
    Kazunori Shimada · 2010 · Health Evaluation and Promotion
  43. Prevalence Trend for 31 Years of Hypertriglyceridemia in Ningen Dock and Resetting of Medical Examination Recommendations through Evaluation of Improvement for Hypertriglyceridemia with Weight Loss
    Takashi Wada, Yasutaka Hasegawa · 2020 · Health Evaluation and Promotion
  44. Anesthesia and Cancer Recurrence
    Umesh Goneppanavar, Jasvinder Kaur · 2021 · Springer eBooks
  45. HEART's Original [症例] 川崎病に起因すると考えられた巨大冠動脈瘤に伴う右冠動脈完全閉塞による若年者狭心症の1例
    賢一 本郷, 尚文 青山, 川井 真, 小武海 公明, 佐久間亨, 芝田 貴裕, 郁夫 谷口, 望月 正武 · 2006 · 心臓
  46. The Circulation Journal Official Impact Factor and the Most Frequently Cited Papers in 2020
    Toshihisa Anzai · 2021 · Circulation Journal
  47. Message From the Editor-in-Chief
    Toshihisa Anzai · 2020 · Circulation Journal
  48. Dyslipidemia
    2006 · Wiley eBooks
  49. Cardiovascular risk prevention in clinical medicine: current guidelines in Asia
    Hae‐Young Lee, Jeong Bae Park · 2022 · Elsevier eBooks
  50. Message From the Editor-in-Chief
    Hiroaki Shimokawa · 2009 · Circulation Journal
  51. Message From the Editor-in-Chief
    Hiroaki Shimokawa · 2010 · Circulation Journal
  52. HDL研究からHDL治療へ(<特集I>基礎科学の進歩)
    Srinivasa T. Reddy · 2011 · Journal of JCS Cardiologists
  53. Message From the Editor-in-Chief
    Toyoaki Murohara · 2018 · Circulation Journal
  54. The Circulation Journal Official Impact Factor and the Most Frequently Cited Papers in 2021
    Toshihisa Anzai · 2022 · Circulation Journal
  55. スタチン治療における海外と国内のエビデンスの比較(6.循環器領域における海外と国内のエビデンスの比較,<特集>第70回日本循環器学会学術集会)
    裕司 渡邉 · 2006 · Journal of JCS Cardiologists
  56. Hypercholesterolemia Influences the Progression of Cancer by Changing the Biomolecular and Immunological Status of the Tumor Microenvironment
    B. Handan Özdemir · 2023 · Springer eBooks
  57. The Circulation Journal Official Impact Factor and the Most Frequently Cited Papers in 2022
    Toshihisa Anzai · 2023 · Circulation Journal
  58. Investigating the Relationship between Body Mass Index, Cholesterol, and Cancer in United States Adults: A Cross-Sectional Study
    Anastasija Martinović, David Rhys Axon · 2024 · Diseases
  59. Hypercholesterolemia Influences the Progression of Cancer by Changing the Biomolecular and Immunological Status of the Tumor Microenvironment
    B. Handan Özdemir · 2025 · Springer eBooks